Wikidata

(Q44673153)

English

Drug development costs when financial risk is measured using the Fama-French three-factor model

scientific article

In more languages

Statements

title
Drug development costs when financial risk is measured using the Fama-French three-factor model (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19655335
retrieved
5 December 2017
author name string
John A Vernon
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
19655335
retrieved
5 December 2017
Joseph H Golec
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
19655335
retrieved
5 December 2017
Joseph A Dimasi
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
19655335
retrieved
5 December 2017
publication date
1 August 2010
1 reference
stated in
Europe PubMed Central
PubMed ID
19655335
retrieved
5 December 2017
page(s)
1002-1005
1 reference
stated in
Europe PubMed Central
PubMed ID
19655335
retrieved
5 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44673153&oldid=2031303361"